Css LLC Neurocrine Biosciences Inc Call Options Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Feb 14, 2020	SELL	$86.8 - $118.57 $1.31 Million - $1.79 Million	-15,100 Reduced 71.56%	6,000 $645,000
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $511,301 - $619,150	6,100 Added 40.67%	21,100 $1.9 Million
Q2 2019 Aug 14, 2019	BUY	$72.24 - $91.27 $700,728 - $885,319	9,700 Added 183.02%	15,000 $1.27 Million
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $367,343 - $485,109	5,300 New	5,300 $466,000

626

94M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.